Software Glitch Scrambles Personal Genomics Data



Loading...

By Kevin Davies

August 27, 2009 | In a commendably thorough piece of investigative journalism, New Scientist San Francisco bureau chief Peter Aldhous has uncovered an intermittent but potentially alarming glitch in the presentation of dozens of variants in his genotyping results from a major consumer genomics firm.

The data in question concerned the presentation in a web browser of several dozen single nucleotide polymorphisms (SNPs) in the mitochondrial DNA reported by deCODEme. The glitch, which Aldhous revealed to deCODE two weeks ago, did not impact any genetic conditions or medical information, and the source of the problem, Aldhous has been told, has been identified and corrected. But the episode reveals another layer of potential error and confusion in the consumer genomics world.

In the 20 months since the launch of deCODEme and 23andMe, firms that offer clients the opportunity to genotype 500,000-1 million SNPs, most of the debate about the value of the firms has centered on analytical and clinical utility. How accurate are the SNP calls on the various genotyping platforms? And how useful is that information in determining a person’s relative risk or medical outcome? Almost taken for granted has been the quality of the software and computing infrastructure used to deliver those data – a not surprising assumption, given the well-publicized relationship between 23andMe and Google and deCODE’s long-standing expertise in informatics and database management.

In meticulously comparing his 23andMe and deCODEme data, however, Aldhous recently made the surprising and serendipitous discovery that no fewer than 44 SNPs in his deCODEme mitochondrial DNA results, as viewed in deCODE’s state-of-the-art genome browser, were sometimes presented incorrectly. Aldhous was able to pinpoint the mistake to the graphical presentation rather than the actual genotypic data by comparing the raw SNP data downloaded from deCODEme and 23andMe, which use essentially the same Illumina platform. The raw data agreed entirely (except for two minor miscalls).

Aldhous said the erroneous presentation, which he describes in an opinion piece in New Scientist, was intermittent, with no apparent reason as to when his results were presented incorrectly. He could even view the mitochondrial data simultaneously on two computers – with one presentation correct, the other incorrect. (There was no problem encountered with the 23andMe presentation.) One genealogist, presented with the conundrum, even said: “Are you sure this is Homo sapiens?”

Aldhous relayed to Bio-IT World what he has learned from deCODE, namely that the error is due to an inconsistency between 32- and 64-bit environments and has now been fixed.

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

oracle20723
The Role of Analytics in Transforming Healthcare
Sponsored by Oracle

Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders.

Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.



pegasystems
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency
Sponsored by Pegasystems

Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are:

  • Potentially stunning return on investment at multiple levels.
  • A 500%, or better, increase in application development time by directly executing business requirements
  • Improved customer retention
  • A 50% possible reduction in training time

Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.



Cmed paper
Next-gen Cloud-based eClinical
Sponsored by Cmed Technology

New technologies are available to leverage Cloud Computing in  managing clinical trial data. This paper discusses a next generation eClinical
platform that:

  • Speeds trial set up
  • Accommodates changes with zero downtime
  • Integrates effectively with other clinical trial technology systems

It is offered with either software-as-a-service (SaaS), or turnkey infrastructure options in which the user organization operates their own cloud using their IT teams, within their data centers. Read this paper to learn and decide how best to leverage cloud computing’s many strengths for your organization’s  particular needs.



Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Web Symposia
Loading...

Bio-IT World proudly presents the Bio-IT World Web Symposia Series covering a broad array of topics within the life sciences and drug development enterprise.

Leveraging BPM to Increase Efficiencies in Clinical Trial Case Management
August 3, 2010 | 1:00 – 2:30 p.m. EST
Sponsored by: Pegasystems
Program Details | Register Here 

 


Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.